Immunotherapy Plus Radiosurgery Can Increase Survival in Patients with Melanoma

Source: Specialty Pharmacy Times, June 2018

Combining radiosurgery with immunotherapy, particularly PD-1 inhibitors, was found to increase survival in patients with melanoma, according to a recently-published study.

Based on the findings, the researchers noted that there is a significant difference in cancer control depending on the type of immunotherapy used, namely anti-PD-1 inhibitors. The study, published in the Journal of Neuro-Oncology, describes the potential advantage of combining these 2 therapies.

read the original full article